obesity drug news today glp-1 2025 How to Invest in Drugs: Stocks and Funds to Watch Alarming rise in weight loss
Description
With obesity rates shooting up, I'd have bet on the sales of generic GLP-1s exploding once their patents expired
"Comparative Analysis of GLP-1 Receptor Agonists in Weight Management." International Journal of Obesity Research, 2023
Glycemic efficacy varies across the GLP-1 class
doi: 10.1038/s41387-020-00134-z 94 ReidDA
Understanding these requirements helps maximise treatment benefits whilst minimising side effects
Thats why its important to work with your care team to find the right dosage for you, rather than skipping doses or adjusting dosage on your own, he says
